Efficacy matters: broadening complement inhibition in COVID-19

Detalles Bibliográficos
Autores principales: Mastellos, Dimitrios C, Skendros, Panagiotis, Calado, Rodrigo T, Risitano, Antonio M, Lambris, John D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836746/
https://www.ncbi.nlm.nih.gov/pubmed/33521674
http://dx.doi.org/10.1016/S2665-9913(20)30423-9
_version_ 1783642812256878592
author Mastellos, Dimitrios C
Skendros, Panagiotis
Calado, Rodrigo T
Risitano, Antonio M
Lambris, John D
author_facet Mastellos, Dimitrios C
Skendros, Panagiotis
Calado, Rodrigo T
Risitano, Antonio M
Lambris, John D
author_sort Mastellos, Dimitrios C
collection PubMed
description
format Online
Article
Text
id pubmed-7836746
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-78367462021-01-26 Efficacy matters: broadening complement inhibition in COVID-19 Mastellos, Dimitrios C Skendros, Panagiotis Calado, Rodrigo T Risitano, Antonio M Lambris, John D Lancet Rheumatol Correspondence Elsevier Ltd. 2021-02 2020-12-14 /pmc/articles/PMC7836746/ /pubmed/33521674 http://dx.doi.org/10.1016/S2665-9913(20)30423-9 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Mastellos, Dimitrios C
Skendros, Panagiotis
Calado, Rodrigo T
Risitano, Antonio M
Lambris, John D
Efficacy matters: broadening complement inhibition in COVID-19
title Efficacy matters: broadening complement inhibition in COVID-19
title_full Efficacy matters: broadening complement inhibition in COVID-19
title_fullStr Efficacy matters: broadening complement inhibition in COVID-19
title_full_unstemmed Efficacy matters: broadening complement inhibition in COVID-19
title_short Efficacy matters: broadening complement inhibition in COVID-19
title_sort efficacy matters: broadening complement inhibition in covid-19
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836746/
https://www.ncbi.nlm.nih.gov/pubmed/33521674
http://dx.doi.org/10.1016/S2665-9913(20)30423-9
work_keys_str_mv AT mastellosdimitriosc efficacymattersbroadeningcomplementinhibitionincovid19
AT skendrospanagiotis efficacymattersbroadeningcomplementinhibitionincovid19
AT caladorodrigot efficacymattersbroadeningcomplementinhibitionincovid19
AT risitanoantoniom efficacymattersbroadeningcomplementinhibitionincovid19
AT lambrisjohnd efficacymattersbroadeningcomplementinhibitionincovid19

Ejemplares similares